Discover undervalued stocks with Eulerpool.

Laboratory Corporation of America Holdings Stock LH

Price

0
Today +/-
-0
Today %
-0 %

Laboratory Corporation of America Holdings stock price

Loading chart...
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Laboratory Corporation of America Holdings stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Laboratory Corporation of America Holdings stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Laboratory Corporation of America Holdings stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Laboratory Corporation of America Holdings's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Laboratory Corporation of America Holdings Stock Price History

DateLaboratory Corporation of America Holdings Price
10/3/20250 undefined
10/3/2025276.94 undefined
10/2/2025279.16 undefined
10/1/2025280.14 undefined
9/30/2025287.34 undefined
9/28/2025282.75 undefined
9/25/2025280.61 undefined
9/24/2025276.14 undefined
9/24/2025279.36 undefined
9/23/2025280.38 undefined
9/22/2025278.91 undefined
9/19/2025277.28 undefined
9/18/2025277.16 undefined
9/17/2025276.08 undefined
9/16/2025274.08 undefined
9/15/2025275.41 undefined
9/12/2025277.95 undefined
9/11/2025279.73 undefined
9/10/2025272.95 undefined
9/9/2025278.68 undefined
9/8/2025277.22 undefined
9/5/2025278.67 undefined
9/4/2025275.24 undefined

Laboratory Corporation of America Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Laboratory Corporation of America Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Laboratory Corporation of America Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Laboratory Corporation of America Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Laboratory Corporation of America Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Laboratory Corporation of America Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Laboratory Corporation of America Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Laboratory Corporation of America Holdings’s growth potential.

Laboratory Corporation of America Holdings Revenue, EBIT and net profit per share

DateLaboratory Corporation of America Holdings RevenueLaboratory Corporation of America Holdings EBITLaboratory Corporation of America Holdings Net Income
2029e16.37 B undefined0 undefined1.9 B undefined
2028e16.42 B undefined2.49 B undefined1.88 B undefined
2027e15.82 B undefined2.3 B undefined1.66 B undefined
2026e15.12 B undefined2.17 B undefined1.53 B undefined
2025e14.43 B undefined2.04 B undefined1.42 B undefined
202413.01 B undefined1.14 B undefined746 M undefined
202312.16 B undefined1.12 B undefined418 M undefined
202211.86 B undefined1.75 B undefined1.28 B undefined
202113.14 B undefined3.07 B undefined2.38 B undefined
202013.98 B undefined3 B undefined1.56 B undefined
201911.55 B undefined1.49 B undefined823.8 M undefined
201811.33 B undefined1.37 B undefined883.7 M undefined
201710.31 B undefined1.38 B undefined1.23 B undefined
20169.55 B undefined1.33 B undefined711.8 M undefined
20158.68 B undefined1.11 B undefined437.6 M undefined
20146.01 B undefined922.1 M undefined511.2 M undefined
20135.81 B undefined1.01 B undefined573.8 M undefined
20125.67 B undefined1.05 B undefined583.1 M undefined
20115.54 B undefined1.03 B undefined519.7 M undefined
20105 B undefined990.8 M undefined558.2 M undefined
20094.69 B undefined949.4 M undefined543.3 M undefined
20084.51 B undefined880.8 M undefined464.5 M undefined
20074.07 B undefined827.6 M undefined476.8 M undefined
20063.59 B undefined698.1 M undefined431.6 M undefined
20053.33 B undefined635 M undefined386.2 M undefined

Laboratory Corporation of America Holdings Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (B)
NET INCOME (B)
NET INCOME GROWTH (%)
DIV. ()
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
1986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e2028e2029e
0.20.270.310.40.50.60.720.760.871.431.681.581.611.71.922.22.512.943.083.333.594.074.514.6955.545.675.816.018.689.5510.3111.3311.5513.9813.1411.8612.1613.0114.4315.1215.8216.4216.37
-32.8415.8728.0324.6320.3619.575.4114.7464.2217.04-5.792.095.3313.0214.5914.0117.234.937.887.9113.3110.744.206.5810.772.332.423.5044.4010.057.919.941.9520.98-6.02-9.692.516.9610.894.784.683.80-0.32
42.6542.4442.6844.2844.3144.9445.2141.5831.5428.4229.3631.6034.9337.0439.9242.0642.3241.6541.8041.7842.5941.5741.5841.9741.9141.0339.6638.2736.6533.4429.8829.9928.0228.1535.4338.0031.2627.6627.8625.1223.9822.9022.0722.14
0.090.120.130.180.220.270.330.320.280.410.490.50.560.630.770.931.061.221.291.391.531.691.871.972.12.272.252.222.22.92.853.093.183.254.954.993.713.363.6200000
0.020.040.050.070.080.10.040.110.03-0.01-0.15-0.130.020.020.080.180.250.320.360.390.430.480.460.540.560.520.580.570.510.440.711.230.880.821.562.381.280.420.751.421.531.661.881.9
-52.1740.0032.6526.1525.61-60.19173.17-73.21-140.001,175.00-15.03-118.46-37.50413.33132.4741.9026.3813.086.3411.6610.44-2.5217.032.76-6.9912.33-1.72-10.82-14.4862.7072.57-28.04-6.8089.0652.76-46.19-67.3278.4790.087.838.6313.061.17
------------------------------------2.882.883.602.882.803.053.443.48
0000000000000000000000000000000000000025-20-2.788.9312.791.16
39.640404039.6239.643735.7833.944.2349.1749.349.9451.5196.3141.08154.2154.7150.7144.9134.7121.3111.8109.1105.4101.897.491.886.4100.6104.3103.9102.698.69897.591.687.684.400000
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Details

Keystats

Revenue and Growth

The Laboratory Corporation of America Holdings Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Laboratory Corporation of America Holdings is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (B)
RECEIVABLES (B)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (B)
TANGIBLE ASSETS (B)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (B)
GOODWILL (B)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (B)
TOTAL ASSETS (B)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (B)
RETAINED EARNINGS (B)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (B)
LIABILITIES (M)
PROVISIONS (B)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (B)
SHORT-TERM REC. (B)
LONG-T. LIAB. (B)
DEFERRED TAXES (B)
OTHER LIAB. (B)
LONG-T. LIABILITIES (B)
DEBT (B)
TOTAL CAPITAL (B)
19871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                                           
00.010.030.050.050.030.010.030.020.030.020.020.040.050.150.060.120.210.060.190.170.220.150.230.160.470.40.580.720.430.320.430.341.321.470.430.541.52
0.050.060.070.060.060.080.120.210.430.510.330.380.350.370.370.390.430.440.490.540.620.630.570.660.70.720.780.821.371.521.851.862.033.022.983.022.12.1
0000008.7321.954.38.8000000000000000000000000000
00000014.920.153.744.33630.729.131.638.744.84761.565.484.380.49190103.4110.8121136.5139.5191205.2227.2237.3244.7423.2401.4470.6474.6493.2
713.213.714.319.163.328.437.782.388128.990.382.163.371.190.955.455.580.474.567.690.5122.9154.190.185.5106.9157.5339.3321.2342.5309373.7364.8478.1707655.3697.6
0.060.080.110.120.140.180.180.290.60.720.530.520.50.510.620.590.660.770.70.890.941.030.941.141.061.391.431.692.622.482.732.842.985.135.334.633.774.81
0.030.030.050.050.060.080.10.140.30.280.250.260.270.270.310.350.360.360.380.390.440.50.50.590.580.630.710.791.751.721.711.782.722.812.93.032.983.05
000000000000000400.6505.3548.5578.9577.96837271.478.576.878.188.592.658.257.658.460.584.973.560.965.726.916.3
00000000000000000000000000000000000000
00000000.130.220.230.220.230.230.250.250.310.570.560.650.610.611.221.341.671.621.671.571.483.323.44.173.914.033.963.743.953.343.49
0.20.20.210.20.210.190.280.420.70.670.630.610.570.620.720.911.291.31.481.481.641.771.92.62.682.93.023.16.26.427.47.367.877.757.968.126.146.37
35.900002520.627.715.821.524.726.513.616.727.32633.19590.448.555.673.590.7103.294.2124.9143.1154.8152.3167.2607.2233.3356.5350.9402.5365.4467652.2
0.260.230.250.250.280.30.40.721.241.21.131.121.091.161.3122.762.863.173.113.433.643.95.045.055.45.535.6111.4811.7713.9413.3515.0714.9515.0515.5312.9613.57
0.320.320.370.370.410.480.591.011.841.921.661.641.591.671.932.583.413.633.8844.374.674.846.196.116.796.977.314.114.2516.6716.1918.0520.0720.3920.1616.7318.38
                                                                           
17.11111110.81.21.2502.1528560714.214.814.915.114.814.413.212.812.512.211.711.310.510.41212.11211.7998.58.17.77.6
0.180.230.230.220.220.230.230.150.410.410.410.420.421.051.081.411.441.51.341.030.250.020.040.0500001.972.131.991.450.030.11000.040
0.10.030.10.030.110.120.20.01-0-0.15-0.28-0.26-0.25-0.170.010.270.590.951.341.772.242.62.933.253.393.593.373.794.224.966.27.087.99.410.4610.587.898.3
000000-2.40000-2-4.2-9.8-22-71.312.374.283.458.7120-16.761.588.545.569.456.1-10.6-287-581.1-333.7-463.1-372.4-161.9-191.9-493.2-59.3-261.6
0000000000000000000000000010.10.10000000000
0.30.270.330.260.330.340.430.170.410.260.630.680.730.881.091.622.062.542.772.872.622.623.043.43.443.673.453.795.926.527.868.087.579.3610.2710.17.888.05
8.76.511.219.625.238.536.944.3106.265.755.950.243.652.860.279.97385.3116.2133.5134.2159.7183.1257.8257.8236.9304.5282.3497.4508.4573.9634.6632.3638.9621.3934.8827.5875.8
0.020.010.020.020.040.040.060.090.160.120.110.10.080.10.090.140.140.150.160.190.170.20.190.260.290.280.250.260.470.480.680.70.991.171.351.110.840.9
027.70.150.3768.528.426.71243.930.128.323.524.831.79.739.965.263.956.375.367.1226.2245.74634.267.491.7310.5285.4517.3521.6607.7881.3798.1728.2549.2544.9
000000000000000000000000000094.542.48.88.2000000
00000000.040.070.0200.070.10.13000.5200.540.550.590.120.420.360.140.480.110.350.330.510.410.010.420.380.010.311.011.01
0.030.050.030.090.070.150.120.20.350.250.20.250.250.310.190.230.770.30.890.930.970.551.021.120.731.030.740.981.71.832.191.882.663.082.783.083.233.33
000000.080.290.560.941.260.690.580.480.350.510.520.360.890.60.61.081.60.981.832.092.182.892.685.945.36.346.045.885.55.55.124.135.41
00000000.020.010.040.030.030.030.030.060.080.270.350.410.410.510.520.580.60.480.550.560.531.181.210.880.940.940.910.760.740.420.38
000.010.020.010.030.030.060.130.110.110.10.10.10.090.140.110.090.090.080.090.190.160.150.290.310.270.270.320.390.440.330.981.21.041.11.061.19
000.010.020.010.120.320.641.081.410.830.710.610.480.660.740.751.331.11.091.682.311.712.582.863.033.723.497.446.97.667.327.87.617.316.965.616.98
0.030.050.040.120.080.260.440.851.431.661.030.960.860.790.840.971.521.631.992.022.642.862.733.73.594.064.464.469.148.739.859.1910.4610.6910.0910.048.8310.31
0.320.320.370.370.410.610.871.011.841.921.661.641.591.671.932.583.574.174.764.895.275.485.777.17.037.737.918.2515.0715.2417.7117.2718.0320.0520.3620.1416.7118.36
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Laboratory Corporation of America Holdings provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Laboratory Corporation of America Holdings's financial health and stability.

Assets

Laboratory Corporation of America Holdings's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Laboratory Corporation of America Holdings must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Laboratory Corporation of America Holdings after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Laboratory Corporation of America Holdings's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (B)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (B)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (B)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (B)
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
19861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.020.040.050.060.080.10.040.110.03-0.01-0.15-0.110.070.070.110.180.250.320.360.390.430.480.480.560.570.530.580.580.510.440.711.230.880.821.562.381.280.42
6810131822263244728486828389104101135138149155162179195203231229230245457499533552577624745633577
0000-4-2-391911-2130-432937-31288638183626699122535627-3354-5252229-47-7518-78
-11-10-19-6169-65-91-90-73-359201-48-5441220-1-263-5455523927-75-74-76-28-172122-70-294-856-263-603-361
000001140-1519822115-703183922231663388485961108968752502122459414969457743899
00000038345865694741402311219193340565055997797117166210239296248216194197221
26303439586282591427-15-55-1223481271351071702332232722113043553093063012842493453483492165001,000504206
0.020.030.040.070.110.140.10.060.010.05-0.190.140.130.180.250.320.440.560.540.570.630.710.780.860.880.860.840.820.740.981.21.51.311.442.143.111.961.33
-3-10-11-23-14-25-34-33-48-75-54-34-58-69-55-88-89-98-102-99-116-143-157-114-126-145-176-202-203-255-278-315-379-400-381-460-481-453
-10-20-11-24-14-37-36-95-293-115-59-38-68-77-150-230-368-730-224-298-273-341-396-334-1,317-280-534-359-350-3,994-795-2,228206-1,283-643-884-1,652-1,171
-7-100-10-12-1-62-244-39-5-3-9-7-94-141-279-631-121-199-156-198-238-219-1,191-134-357-157-146-3,739-516-1,913586-882-261-424-1,170-717
00000000000000000000000000000000000000
0-00000000.320.360.27-0.59-0.04-0.07-0.10.02-0.210.35-00.250.030.470.05-0.340.790.030.430.33-0.023.11-0.650.92-0.70.21-0.41-0.380-0.3
0045001-56490186048823171418-133-311-521-394-843-269-248-254-525-430-841-1549826-264-630-385-44-1,616-1,049-945
-0-0.02-0.02-0.03-0.08-0.09-0.080.020.290.060.26-0.11-0.06-0.09-0.090.02-0.170.21-0.31-0.28-0.35-0.36-0.22-0.60.52-0.650-0.52-0.23.18-0.670.59-1.39-0.25-0.52-2.07-1.32-0.06
0.01-0.01-0.06-0.03-0.08-0.070-0-0.01-0.49-0.01-0000-0.020.02-00-00.010.010-0.01-0.02-0.15-0-0-0.03-0.02-0.04-0.07-0.05-0.08-0.06-0.07-0.081.44
-150000-25-28-29-1300-9-18-18-9000000000000000000000-195-254
3-31219135-17-2114-1012-60178100-92460-264163-7182-71307-62176136-282-116110-89983151-1,042106
15.723.928.848.197.5109.967.523.6-34.2-28.4-240.9109.966.4111.1191.2227.9355.6465.7435.2475.2515.8566.4623.4747.7757.1709.9665.1616.5535.5726.6918.21,182.7925.61,044.51,753.62,649.21,474874.1
00000000000000000000000000000000000000

Laboratory Corporation of America Holdings stock margins

The Laboratory Corporation of America Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Laboratory Corporation of America Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Laboratory Corporation of America Holdings.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Laboratory Corporation of America Holdings's sales revenue. A higher gross margin percentage indicates that the Laboratory Corporation of America Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Laboratory Corporation of America Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Laboratory Corporation of America Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Laboratory Corporation of America Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Laboratory Corporation of America Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Laboratory Corporation of America Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Laboratory Corporation of America Holdings Margin History

Laboratory Corporation of America Holdings Gross marginLaboratory Corporation of America Holdings Profit marginLaboratory Corporation of America Holdings EBIT marginLaboratory Corporation of America Holdings Profit margin
2029e27.86 %0 %11.61 %
2028e27.86 %15.16 %11.44 %
2027e27.86 %14.55 %10.5 %
2026e27.86 %14.34 %10.12 %
2025e27.86 %14.11 %9.83 %
202427.86 %8.75 %5.73 %
202327.67 %9.24 %3.44 %
202231.26 %14.77 %10.78 %
202138.01 %23.39 %18.1 %
202035.43 %21.48 %11.13 %
201928.15 %12.86 %7.13 %
201828.03 %12.12 %7.8 %
201729.99 %13.35 %11.9 %
201629.88 %13.91 %7.45 %
201533.45 %12.8 %5.04 %
201436.65 %15.34 %8.5 %
201338.28 %17.44 %9.88 %
201239.67 %18.49 %10.28 %
201141.04 %18.57 %9.38 %
201041.92 %19.8 %11.16 %
200941.98 %20.22 %11.57 %
200841.59 %19.55 %10.31 %
200741.57 %20.34 %11.72 %
200642.59 %19.44 %12.02 %
200541.78 %19.08 %11.61 %

Laboratory Corporation of America Holdings Stock Sales Revenue, EBIT, Earnings per Share

The Laboratory Corporation of America Holdings earnings per share therefore indicates how much revenue Laboratory Corporation of America Holdings has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Laboratory Corporation of America Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Laboratory Corporation of America Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Laboratory Corporation of America Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Laboratory Corporation of America Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Laboratory Corporation of America Holdings Revenue, EBIT and net profit per share

DateLaboratory Corporation of America Holdings Sales per ShareLaboratory Corporation of America Holdings EBIT per shareLaboratory Corporation of America Holdings Earnings per Share
2029e193.97 undefined0 undefined22.52 undefined
2028e194.6 undefined0 undefined22.26 undefined
2027e187.48 undefined0 undefined19.69 undefined
2026e179.09 undefined0 undefined18.12 undefined
2025e170.91 undefined0 undefined16.8 undefined
2024154.13 undefined13.48 undefined8.84 undefined
2023138.83 undefined12.83 undefined4.77 undefined
2022129.52 undefined19.13 undefined13.96 undefined
2021134.73 undefined31.51 undefined24.38 undefined
2020142.64 undefined30.64 undefined15.88 undefined
2019117.19 undefined15.07 undefined8.35 undefined
2018110.46 undefined13.39 undefined8.61 undefined
201799.21 undefined13.24 undefined11.81 undefined
201691.59 undefined12.74 undefined6.82 undefined
201586.28 undefined11.04 undefined4.35 undefined
201469.58 undefined10.67 undefined5.92 undefined
201363.27 undefined11.03 undefined6.25 undefined
201258.23 undefined10.77 undefined5.99 undefined
201154.44 undefined10.11 undefined5.11 undefined
201047.48 undefined9.4 undefined5.3 undefined
200943.03 undefined8.7 undefined4.98 undefined
200840.3 undefined7.88 undefined4.15 undefined
200733.54 undefined6.82 undefined3.93 undefined
200626.66 undefined5.18 undefined3.2 undefined
200522.96 undefined4.38 undefined2.67 undefined

Laboratory Corporation of America Holdings business model

The Laboratory Corporation of America Holdings, also known as LabCorp, is an American company that has been operating in the medical diagnostics industry since 1978. It was founded by a doctor and a laboratory scientist with the goal of simplifying and improving the diagnostic process. LabCorp is now the largest independent diagnostic company in the world, with over 60,000 employees. LabCorp's business model is to contribute to the prevention, diagnosis, and treatment of diseases through its comprehensive diagnostic services. The company offers a wide range of medical laboratory tests, clinical studies, and DNA analysis services. LabCorp operates more than 2,000 locations in the United States, Canada, and Europe, and provides its services worldwide. LabCorp is divided into three business segments: Diagnostics, Drug Development, and CRO (contract research organization). Under the Diagnostics segment, the company offers laboratory tests for clinical detection, cancer diagnosis, genetic testing, and more. The company specializes in blood, body fluid, and tissue analyses and also offers a variety of specialized tests to answer specific medical questions. LabCorp's Drug Development segment aims to accelerate and improve drug development through its comprehensive clinical studies. The company assists with study coordination and compliance with regulatory requirements to ensure accurate and reliable study results. LabCorp's CRO segment offers clinical study services, including study planning, design, execution, and analysis. This enables the company to develop groundbreaking treatment options for diseases that do not yet have adequate therapies. LabCorp is also heavily involved in the development of personalized diagnostics to provide patients with even more accurate diagnosis and treatment options. LabCorp offers a wide range of products. The company is a leading provider of clinical laboratory services and offers a broad range of laboratory tests for infections, hormonal disorders, autoimmune diseases, allergies, and cancer. Some of the specialized tests offered by LabCorp include genetic testing for cancer diagnosis and inherited metabolic disorders. In the Drug Development segment, the company offers a wide range of clinical studies aimed at developing new drugs and therapies. LabCorp also utilizes its DNA identification services to confirm the identity of individuals or assist in forensic cases. In summary, LabCorp is a successful company specialized in medical diagnostics. Over the past 40 years, the company has experienced impressive growth and positioned itself as a leading provider of clinical laboratory services. With its wide range of diagnostic services, clinical studies, and DNA identification services, LabCorp provides innovative solutions for the medical challenges of the future. Laboratory Corporation of America Holdings is one of the most popular companies on Eulerpool.com.

Laboratory Corporation of America Holdings SWOT Analysis

Strengths

Laboratory Corporation of America Holdings (LabCorp) has a strong brand reputation in the healthcare industry as a leading provider of clinical laboratory services.

LabCorp has a wide network of laboratories and facilities, allowing for efficient and timely delivery of services to customers across the United States.

The company has a diverse portfolio of testing services and diagnostic solutions, offering a comprehensive range of medical testing options to healthcare providers and patients.

LabCorp benefits from strategic partnerships and collaborations with pharmaceutical companies, healthcare providers, and research institutions, enhancing its market presence and facilitating innovation.

Weaknesses

LabCorp faces intense competition from other prominent laboratory service providers, which may impact its market share and pricing power.

The company heavily relies on third-party payers, such as insurance companies and government healthcare programs, for a significant portion of its revenue. Any changes in reimbursement policies or reduced payment rates could negatively affect LabCorp's financial performance.

LabCorp's dependence on advanced technology and laboratory equipment makes it vulnerable to disruptions in supply chains or the introduction of more efficient technologies by competitors.

Opportunities

The growing demand for personalized medicine and genetic testing presents opportunities for LabCorp to expand its portfolio of services and capture a larger market share.

Expansion into international markets can provide LabCorp with access to new customer segments and revenue streams.

Technological advancements, such as digital health platforms and telemedicine, offer LabCorp the chance to enhance its service delivery and improve patient experience.

Threats

Regulatory changes and compliance requirements in the healthcare industry can pose challenges and increase operating costs for LabCorp.

The ongoing COVID-19 pandemic has disrupted healthcare systems worldwide, leading to potential lower demand for non-essential testing services.

Competitors' consolidation or entry into LabCorp's key markets may intensify competition and put pressure on the company's market position and profitability.

Laboratory Corporation of America Holdings Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details
Details

Revenue by Segment

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Laboratory Corporation of America Holdings Revenue by Segment

Segmente20192018
LabCorp Diagnostics7 B USD7.03 B USD
Covance Drug Development4.58 B USD4.31 B USD

Laboratory Corporation of America Holdings Revenue by Region

  • 3 years

  • 5 years

  • Max

Details
Details

Revenue by Segment

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Laboratory Corporation of America Holdings Revenue by Segment

DateCANADAEuropeNorth AmericaOther countriesSWITZERLANDUNITED KINGDOMUnited States
2021-2.05 B USD13.09 B USD976.4 M USD---
2020-1.51 B USD11.53 B USD941 M USD---
2019333.3 M USD--1.2 B USD532.9 M USD507.9 M USD8.98 B USD
2018342.2 M USD--2.5 M USD-21.8 M USD6.66 B USD
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Laboratory Corporation of America Holdings Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Laboratory Corporation of America Holdings historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Laboratory Corporation of America Holdings shares outstanding

The number of shares was Laboratory Corporation of America Holdings in 2024 — This indicates how many shares 84.4 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Laboratory Corporation of America Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Laboratory Corporation of America Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Laboratory Corporation of America Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Laboratory Corporation of America Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Laboratory Corporation of America Holdings stock splits

In Laboratory Corporation of America Holdings's history, there have been no stock splits.

Laboratory Corporation of America Holdings dividend history and estimates

In 2024, Laboratory Corporation of America Holdings paid a dividend amounting to 3.6 undefined. Dividend means that Laboratory Corporation of America Holdings distributes a portion of its profits to its owners.
  • Max

Dividend
Dividend (Estimate)
Details
Details

Dividend

Dividend Overview

The dividend per year chart for Laboratory Corporation of America Holdings provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Laboratory Corporation of America Holdings’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Laboratory Corporation of America Holdings's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Laboratory Corporation of America Holdings Dividend History

DateLaboratory Corporation of America Holdings Dividend
2029e3.48 undefined
2028e3.44 undefined
2027e3.05 undefined
2026e2.8 undefined
2025e0.72 undefined
2022e0.72 undefined
2025e2.16 undefined
20243.6 undefined
20232.88 undefined
2022e2.16 undefined

Laboratory Corporation of America Holdings dividend payout ratio

In 2024, Laboratory Corporation of America Holdings had a payout ratio of 15.47%. The payout ratio indicates the percentage of the company's profits that Laboratory Corporation of America Holdings distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Laboratory Corporation of America Holdings represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Laboratory Corporation of America Holdings could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Laboratory Corporation of America Holdings's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Laboratory Corporation of America Holdings Payout Ratio History

DateLaboratory Corporation of America Holdings Payout ratio
2029e15.47 %
2028e15.47 %
2027e15.47 %
2026e15.47 %
2025e15.47 %
202415.47 %
202315.47 %
202215.47 %
202115.47 %
202015.47 %
201915.47 %
201815.47 %
201715.47 %
201615.47 %
201515.47 %
201415.47 %
201315.47 %
201215.47 %
201115.47 %
201015.47 %
200915.47 %
200815.47 %
200715.47 %
200615.47 %
200515.47 %
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Laboratory Corporation of America Holdings.

Laboratory Corporation of America Holdings latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20254.29 4.35  (1.34 %)2025 Q2
3/31/20253.85 3.84  (-0.37 %)2025 Q1
12/31/20243.49 3.45  (-1.09 %)2024 Q4
9/30/20243.59 3.5  (-2.46 %)2024 Q3
6/30/20243.89 3.94  (1.29 %)2024 Q2
3/31/20243.59 3.68  (2.61 %)2024 Q1
12/31/20233.36 3.3  (-1.64 %)2023 Q4
9/30/20233.43 3.38  (-1.54 %)2023 Q3
6/30/20233.64 3.8  (4.4 %)2023 Q2
3/31/20234.07 3.82  (-6.24 %)2023 Q1
1
2
3
4
5
...
12

Eulerpool ESG Scorecard© for the Laboratory Corporation of America Holdings stock

Eulerpool World ESG Rating (EESG©)

85/ 100

🌱 Environment

99

👫 Social

98

🏛️ Governance

58

Environment

Scope 1 - Direct Emissions
182,265
Scope 2 - Indirect emissions from purchased energy
155,929
Scope 3 - Indirect emissions within the value chain
1,050,378
Total CO₂ emissions
338,194
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees70
Percentage of women in management
Percentage of Asian employees10
Share of Asian management9
Percentage of Hispanic/Latino employees14
Hispano/Latino Management share8
Percentage of Black employees25
Black Management Share15
Percentage of white employees49
White Management Share66
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Laboratory Corporation of America Holdings shareholders

%
Name
Stocks
Change
Date
11.50111 % The Vanguard Group, Inc.9,706,938-446,95112/31/2023
5.46435 % BlackRock Institutional Trust Company, N.A.4,611,910-438,08612/31/2023
4.46716 % State Street Global Advisors (US)3,770,286-56,25712/31/2023
2.85434 % BlackRock Financial Management, Inc.2,409,067-571,15912/31/2023
2.66362 % Wellington Management Company, LLP2,248,093-239,01312/31/2023
2.21621 % Geode Capital Management, L.L.C.1,870,479-48,24812/31/2023
2.15755 % Lazard Asset Management, L.L.C.1,820,972-391,52512/31/2023
1.91215 % Allspring Global Investments, LLC1,613,854597,5713/31/2024
1.71381 % Dimensional Fund Advisors, L.P.1,446,454-8,52412/31/2023
1.68704 % Diamond Hill Capital Management Inc.1,423,860142,97612/31/2023
1
2
3
4
5
...
10

Laboratory Corporation of America Holdings Executives and Management Board

Mr. Adam Schechter

(58)
Laboratory Corporation of America Holdings Chairman of the Board, President, Chief Executive Officer (since 2013)
Compensation 14.93 M

Mr. Glenn Eisenberg

(61)
Laboratory Corporation of America Holdings Chief Financial Officer, Executive Vice President
Compensation 8.68 M

Dr. Brian Caveney

(49)
Laboratory Corporation of America Holdings Executive Vice President, President Early Development and Chief Medical and Scientific Officer
Compensation 3.01 M

Mr. Mark Schroeder

(62)
Laboratory Corporation of America Holdings Executive Vice President, President Diagnostics and Chief Operations Officer
Compensation 2.84 M

Mr. Lance Berberian

(60)
Laboratory Corporation of America Holdings Executive Vice President, Chief Information and Technology Officer
Compensation 2.7 M
1
2
3
4
...
5

Laboratory Corporation of America Holdings Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,820,320,110,020,05-0,33
SupplierCustomer0,62-0,120,800,850,760,90
SupplierCustomer0,610,530,800,350,240,65
SupplierCustomer0,600,55-0,380,650,430,50
SupplierCustomer0,520,230,670,580,20-0,59
SupplierCustomer0,440,270,340,770,510,81
SupplierCustomer0,390,390,760,900,640,41
SupplierCustomer0,39-0,050,20-0,61-0,470,57
SupplierCustomer0,380,260,600,830,540,63
SupplierCustomer0,33-0,200,260,680,14-0,85
1
2
3

Most common questions regarding Laboratory Corporation of America Holdings

What values and corporate philosophy does Laboratory Corporation of America Holdings represent?

Laboratory Corporation of America Holdings (LabCorp) represents a strong commitment to high-quality diagnostic services and leading advancements in healthcare. LabCorp values innovation, integrity, and collaboration, ensuring accurate and timely results for patients and healthcare providers worldwide. Their corporate philosophy emphasizes a patient-centric approach, focusing on bettering patient outcomes through advanced testing capabilities and personalized care. LabCorp's dedication to cutting-edge technology, scientific expertise, and ethical practices positions them as a trusted leader in the diagnostic industry. With a relentless pursuit of excellence, LabCorp strives to improve healthcare access and foster healthier communities through their comprehensive range of laboratory and diagnostic solutions.

In which countries and regions is Laboratory Corporation of America Holdings primarily present?

Laboratory Corporation of America Holdings (LabCorp) primarily operates in the United States. With a network of over 2,000 patient service centers, LabCorp serves patients in all 50 states. As a leading global life sciences company, LabCorp also has international operations and serves clients in several countries worldwide. However, the company's core presence and operations are primarily focused on delivering comprehensive laboratory testing services within the United States.

What significant milestones has the company Laboratory Corporation of America Holdings achieved?

Laboratory Corporation of America Holdings (LabCorp) has achieved several significant milestones in its history. One notable milestone was its founding in 1978, which established LabCorp as an independent clinical laboratory. Over the years, LabCorp has gained a reputation for providing high-quality and comprehensive diagnostic services, making it one of the leading providers in the healthcare industry. With continuous innovation and strategic acquisitions, LabCorp has expanded its capabilities, becoming a pioneer in advanced diagnostic testing, drug development services, and genomic testing. Furthermore, LabCorp's commitment to delivering accurate and timely results has earned the trust of healthcare professionals and patients alike, solidifying its position as a reliable and trusted leader in the industry.

What is the history and background of the company Laboratory Corporation of America Holdings?

Laboratory Corporation of America Holdings, commonly known as LabCorp, is a leading provider of individualized healthcare diagnostics and innovative testing services. Founded in 1978 and headquartered in Burlington, North Carolina, LabCorp has grown to become a global life sciences company. With a strong focus on scientific expertise and technological advancements, LabCorp offers a wide range of testing options across various medical specialties, including pathology, oncology, genetics, reproductive health, and clinical trials. LabCorp's commitment to high-quality and efficient diagnostics has bolstered its reputation as a trusted provider in the healthcare industry. Continuously striving to improve patient care and outcomes, LabCorp remains at the forefront of diagnostic innovation.

Who are the main competitors of Laboratory Corporation of America Holdings in the market?

The main competitors of Laboratory Corporation of America Holdings in the market include Quest Diagnostics, Bio-Reference Laboratories, and Sonic Healthcare.

In which industries is Laboratory Corporation of America Holdings primarily active?

Laboratory Corporation of America Holdings (LabCorp) is primarily active in the healthcare industry, specifically in the life sciences and diagnostics sectors. As a leading global life sciences company, LabCorp offers a wide range of laboratory testing and diagnostic services. They serve various industries such as pharmaceuticals, biotechnology, hospitals, clinics, academic institutions, and contract research organizations. LabCorp plays a crucial role in supporting medical professionals, researchers, and patients by providing reliable and accurate testing solutions that contribute to the advancement of healthcare.

What is the business model of Laboratory Corporation of America Holdings?

The business model of Laboratory Corporation of America Holdings primarily revolves around providing comprehensive laboratory testing services to healthcare providers, pharmaceutical companies, and individuals. As one of the largest clinical laboratory networks globally, Laboratory Corporation of America Holdings offers a wide range of testing services, including clinical research, cancer diagnostics, toxicology screenings, genetic testing, and general laboratory testing. Through their extensive network of laboratories and cutting-edge technologies, the company aims to deliver accurate and timely results to support healthcare diagnosis, treatment decisions, and drug development. Laboratory Corporation of America Holdings is committed to improving health outcomes by offering innovative laboratory solutions to its customers.

What is the P/E ratio of Laboratory Corporation of America Holdings 2025?

The P/E ratio cannot be calculated for Laboratory Corporation of America Holdings at the moment.

What is the P/S ratio of Laboratory Corporation of America Holdings 2025?

The P/S cannot be calculated for Laboratory Corporation of America Holdings currently.

What is the Quality Investing of Laboratory Corporation of America Holdings?

The Quality Investing for Laboratory Corporation of America Holdings is 3/10.

What is the revenue of Laboratory Corporation of America Holdings 2025?

The expected Laboratory Corporation of America Holdings revenue is 14.43 B USD.

How high is the profit of Laboratory Corporation of America Holdings 2025?

The expected Laboratory Corporation of America Holdings profit is 1.42 B USD.

What is the business model of Laboratory Corporation of America Holdings

LabCorp is a leading company in the field of clinical diagnostics, providing medical diagnostic services to doctors, hospitals, and other healthcare facilities. It is divided into three main business segments: Diagnostics, Drug Development, and Technology Solutions. LabCorp offers a wide range of laboratory tests for different diseases and medical needs, conducts clinical studies for pharmaceutical and biotechnology companies, and provides IT solutions and support for medical facilities. It also has joint ventures and partnerships with other companies, including Covance, a leading provider of clinical development and laboratory services. LabCorp aims to improve healthcare through clinical diagnostics and innovative technology solutions. It has a strong market position, a diverse customer base, and generated a revenue of $14.9 billion in 2020.

What is the Laboratory Corporation of America Holdings dividend?

Laboratory Corporation of America Holdings pays a dividend of 2.16 USD distributed over payouts per year.

How often does Laboratory Corporation of America Holdings pay dividends?

The dividend cannot currently be calculated for Laboratory Corporation of America Holdings or the company does not pay out a dividend.

What is the Laboratory Corporation of America Holdings ISIN?

The ISIN of Laboratory Corporation of America Holdings is US50540R4092.

What is the Laboratory Corporation of America Holdings WKN?

The WKN of Laboratory Corporation of America Holdings is 895308.

What is the Laboratory Corporation of America Holdings ticker?

The ticker of Laboratory Corporation of America Holdings is LH.

How much dividend does Laboratory Corporation of America Holdings pay?

Over the past 12 months, Laboratory Corporation of America Holdings paid a dividend of 3.6 USD . This corresponds to a dividend yield of about . For the coming 12 months, Laboratory Corporation of America Holdings is expected to pay a dividend of 2.8 USD.

What is the dividend yield of Laboratory Corporation of America Holdings?

The current dividend yield of Laboratory Corporation of America Holdings is .

When does Laboratory Corporation of America Holdings pay dividends?

Laboratory Corporation of America Holdings pays a quarterly dividend. This is distributed in the months of December, March, June, September.

How secure is the dividend of Laboratory Corporation of America Holdings?

Laboratory Corporation of America Holdings paid dividends every year for the past 8 years.

What is the dividend of Laboratory Corporation of America Holdings?

For the upcoming 12 months, dividends amounting to 2.8 USD are expected. This corresponds to a dividend yield of 1.01 %.

In which sector is Laboratory Corporation of America Holdings located?

Laboratory Corporation of America Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Laboratory Corporation of America Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Laboratory Corporation of America Holdings from 9/11/2025 amounting to 0.72 USD, you needed to have the stock in your portfolio before the ex-date on 8/28/2025.

When did Laboratory Corporation of America Holdings pay the last dividend?

The last dividend was paid out on 9/11/2025.

What was the dividend of Laboratory Corporation of America Holdings in the year 2024?

In the year 2024, Laboratory Corporation of America Holdings distributed 2.88 USD as dividends.

In which currency does Laboratory Corporation of America Holdings pay out the dividend?

The dividends of Laboratory Corporation of America Holdings are distributed in USD.

All fundamentals about Laboratory Corporation of America Holdings

Our stock analysis for Laboratory Corporation of America Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Laboratory Corporation of America Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.